Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy.
アクセス数 : 755 件
ダウンロード数 : 336 件
今月のアクセス数 : 0 件
今月のダウンロード数 : 0 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00044280
| File | |
| File | |
| File | |
| Title ( eng ) |
Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy.
|
| Title ( jpn ) |
胆道癌患者に対するGemcitabineを用いた術後補助化学療法においてhuman equilibrative mucleoside transporter 1およびribonucleotide reductase regulatory subunit M1発現の同時解析は予後の予測価値を高める
|
| Creator |
Sasaki Hayato
|
| NDC |
Medical sciences [ 490 ]
|
| Language |
eng
|
| Resource Type | doctoral thesis |
| Rights |
Copyright (c) by Author
|
| Publish Type | Not Applicable (or Unknown) |
| Access Rights | open access |
| Source Identifier |
British Journal of Cancer, 111(7), 1275–1284, Sep 2014
[DOI] https://doi.org/10.1038/bjc.2014.399
|
| Dissertation Number | 甲第6654号 |
| Degree Name | |
| Date of Granted | 2015-03-23 |
| Degree Grantors |
広島大学
|
